10% OFF DISCOUNT FOR VETERANS & FIRST RESPONDERS 
We are committed to making a positive impact on mental health awareness! Five percent [5%] of all profits will be directly donated to mental health related causes.
For people living with depression, finding an effective treatment can take time. Traditional antidepressants, including selective serotonin reuptake inhibitors (SSRIs), are commonly prescribed, but they don’t work equally well for everyone. Some people experience limited improvement, persistent symptoms, or side effects that make treatment difficult.
As interest in alternative treatment approaches grows, many patients are asking about ketamine vs antidepressants and how these options compare.
At K Plus Clinics in Winter Park, Florida, we provide medically supervised IV ketamine therapy for eligible patients throughout Orlando and Central Florida. Understanding the differences can help you have a more informed conversation with your healthcare provider.
Traditional antidepressants influence chemical signaling in the brain. SSRIs, such as sertraline, fluoxetine, and escitalopram, primarily affect serotonin, a neurotransmitter involved in mood regulation.
Other medications, including serotonin-norepinephrine reuptake inhibitors (SNRIs), affect additional neurotransmitter systems.
These medications are established treatments for depression and several anxiety disorders. However, finding the right medication and dosage sometimes requires adjustments over time.
Many antidepressants take several weeks to produce their full therapeutic effects. Common side effects may include nausea, sleep changes, sexual dysfunction, and gastrointestinal discomfort, although experiences vary.
One of the most important differences between ketamine and antidepressants is how they interact with the brain.
Unlike SSRIs, ketamine primarily acts on the glutamate system, particularly through effects involving N-methyl-D-aspartate (NMDA) receptors.
Glutamate plays an important role in communication between brain cells. Researchers believe ketamine’s effects may influence neuroplasticity, the brain’s ability to adapt and form new connections.
Although these mechanisms are still being studied, clinical research suggests ketamine may reduce depressive symptoms in some patients who haven’t responded adequately to conventional treatments.
At K Plus Clinics, IV ketamine is administered under medical supervision, with individualized screening and monitoring.
Treatment timelines are another important distinction.
Traditional antidepressants generally require several weeks before their full benefits become apparent. Ketamine, by comparison, has demonstrated antidepressant effects within hours or days in some clinical studies.
However, rapid improvement isn’t guaranteed, and responses can differ significantly between patients.
Ketamine’s antidepressant effects may also be temporary. Some patients undergo a series of infusions, followed by reassessment and possible maintenance treatments when clinically appropriate.
The goal is not simply rapid symptom reduction, but thoughtful treatment planning based on each patient’s needs and response.
Research supporting ketamine is strongest for treatment-resistant depression, generally referring to depression that hasn’t improved adequately after multiple appropriate treatment attempts.
A randomized clinical trial published in the American Journal of Psychiatry found that patients receiving IV ketamine experienced greater short-term improvement in depressive symptoms than those receiving an active placebo.
Other research has supported ketamine’s potential for rapid antidepressant effects, although questions remain about long-term outcomes, optimal maintenance schedules, and patient selection.
It’s also important to distinguish IV ketamine from esketamine (Spravato), a related nasal spray with specific FDA-approved psychiatric indications.
IV ketamine for depression is an off-label treatment. Ketamine itself is FDA-approved as an anesthetic, but its use for psychiatric conditions has not received separate FDA approval.
Not necessarily.
Ketamine therapy should not automatically be viewed as a replacement for antidepressant medications, psychotherapy, or ongoing psychiatric care.
Some patients may receive ketamine alongside existing treatments, depending on their medical history, medications, and recommendations from their healthcare team.
Others may need adjustments to their overall treatment plan.
Patients should never stop taking prescribed antidepressants without consulting their prescribing clinician. Abrupt discontinuation can cause withdrawal symptoms or worsening mental health symptoms.
A coordinated approach helps ensure treatment decisions account for both potential benefits and risks.
IV ketamine may be considered for certain patients with treatment-resistant depression, particularly when conventional approaches haven’t provided adequate relief.
Before treatment, a medical evaluation should review psychiatric history, physical health, current medications, and potential contraindications.
Ketamine can cause temporary increases in blood pressure, dissociation, nausea, and other side effects. It is not appropriate for everyone.
For patients exploring ketamine vs antidepressants, the most useful next step is discussing their treatment history and goals with qualified healthcare professionals.
At K Plus Clinics, we understand that mental health treatment is personal. Our Winter Park clinic offers medically supervised IV ketamine therapy with an emphasis on individualized care, patient education, and ongoing support.
If traditional antidepressants haven’t provided the improvement you hoped for, learning about additional treatment options may be worthwhile.
Schedule a consultation with K Plus Clinics to ask questions, review your options, and learn whether IV ketamine therapy may be appropriate for you.
